Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wolfgang Halfbrodt is active.

Publication


Featured researches published by Wolfgang Halfbrodt.


Tetrahedron | 1999

7α,15α-Ethano bridged steroids. Synthesis and progesterone receptor interaction

Ursula Egner; Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Nikolaus Heinrich; Joachim Kuhnke; Anke Müller-Fahrnow; Günter Neef; Klaus Schöllkopf; Wolfgang Schwede

Abstract The synthesis of 7α,15α-ethano bridged steroids is described. Diels-Alder reaction of 3-methoxyestra-1,3,5(10),7,14-pentaen-17-one 4 with ethylene under high pressure provides efficient synthetic access to this class of steroids. Compounds 15 and 17 were tested for their binding affinities to the progesterone receptor (PR). Two low energy conformations 17a and 17b could be identified by force field calculations of compound 17. Both conformations were analysed in complex with the ligand binding domain of the human progesterone receptor (hPR LBD).


Steroids | 1998

Synthesis and Biological Activity of 11,19-Bridged Progestins

Wolfgang Schwede; Karl-Heinrich Fritzemeier; Wolfgang Halfbrodt; Rolf Krattenmacher; Peter Muhn; Günter Neef; Eckhard Ottow; Klaus Schöllkopf

A synthetic approach to 11,19-bridged progestins is described. The key step in the synthesis is a 6-endo-trig radical cyclisation. The new progestins were tested for their biological activities in vitro and in vivo and compared to those of known progestins.


Archive | 2002

1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

Thorsten Blume; Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Moenning; Herbert Schneider; Bernd Elger


Archive | 2005

1,2 Diarylbenzimidazoles and their pharmaceutical use

Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Moenning


Archive | 2002

1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives

Thorsten Blume; Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Moenning; Bernd Elger; Herbert Schneider


Archive | 2001

1,2 diarylbenzimdazoles and their pharmaceutical use

Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Moenning


Archive | 2005

1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives

Thorsten Blume; Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Mönning; Herbert Schneider


Archive | 2002

Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases

Thorsten Blume; Wolfgang Halfbrodt; Joachim Kuhnke; Ursula Moenning; Herbert Schneider


Archive | 1994

Gestagen-effective 4,5;11,12-estradienes, process for their production, medicaments containing these estradienes and their use in producing medicaments

Wolfgang Schwede; Wolfgang Halfbrodt; Günter Neef; Eckhard Ottow; Klaus Schöllkopf; Rolf Krattenmacher; Karl-Heinrich Fritzemeier


Archive | 1993

Progestationally active 19,11-bridged 4-estrenes

Eckhard Ottow; Wolfgang Schwede; Wolfgang Halfbrodt; Karl-Heinrich Fritzemeier; Rolf Krattenmacher

Collaboration


Dive into the Wolfgang Halfbrodt's collaboration.

Researchain Logo
Decentralizing Knowledge